Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pharmacology|April 17, 2001
Pharmacokinetic and pharmacodynamic characteristics and safety of inhaled albuterol enantiomers in healthy volunteersK Gumbhir-Shah, D J Kellerman, S DeGraw, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|May 12, 1998
Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled studyM J Noonan, P Chervinsky, J Wolfe, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 1, 1996
Fluticasone propionate compared with theophylline for mild-to-moderate asthmaS P Galant, M Lawrence, E O Meltzer, et al.
The Journal of Nervous and Mental Disease|February 1, 1982
beta-Endorphin immunoreactivity and acute behavioral distress in children with leukemiaE R Katz, B Sharp, J Kellerman, et al.
Drug Design, Development and Therapy|August 9, 2013
Assessing acute systemic effects of an inhaled drug with serial echocardiography: a placebo-controlled comparison of inhaled and intravenous dihydroergotamineRobert J Noveck, Pamela S Douglas, Shein-Chung Chow, et al.
The Journal of Headache and Pain|May 18, 2021
Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraineStephanie J Nahas, Nada Hindiyeh, Deborah I Friedman, et al.
Headache|May 22, 2018
Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled TrialDavid W Dodick, Stewart J Tepper, Deborah I Friedman, et al.
Cephalalgia : an International Journal of Headache|October 13, 2017
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraineEgilius Lh Spierings, Jan Lewis Brandes, David B Kudrow, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 1, 1997
Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthmaD S Pearlman, M J Noonan, D P Tashkin, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 1, 1996
A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthmaS I Wasserman, G N Gross, W F Schoenwetter, et al.
Pageof 5